Ambys Medicines Company Profile, Contacts & Intelligence
Ambys Medicines Overview
Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins.
- Headquarters
- 131 Oyster Point Blvd
- Website
- ambys.com
- Industry
- Biotechnology Research
- Founded
- 2018
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
- Phone Number
- Available in AeroLeads
- Company Email
- Available in AeroLeads
Ambys Medicines Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Ambys Medicines People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Ambys Medicines Workforce Composition
Seniority breakdown across 7 visible profiles.
Ambys Medicines Technology & Talent
Technology-related job titles represented in the visible people data.
Compare Similar Companies to Ambys Medicines
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Revolution Medicines | Biotechnology Research | 737 | View company |
| Tessera Therapeutics | Biotechnology Research | 326 | View company |
| Arsenal Biosciences, Inc. | Biotechnology Research | 298 | View company |
| Sangamo Therapeutics, Inc. | Biotechnology Research | 267 | View company |
| Alumis | Biotechnology Research | 216 | View company |
| Metagenomi | Biotechnology Research | 204 | View company |
| Maze Therapeutics | Biotechnology Research | 146 | View company |
| Septerna | Biotechnology | 108 | View company |
| GenEdit | Biotechnology Research | 55 | View company |
| Belharra Therapeutics | Biotechnology Research | 41 | View company |